Medebound HEALTH7 min readBlogThe First Targeted Therapy for KRAS-Mutated Ovarian Cancer: A 44% Response Rate, Now Available in the U.S.
Medebound HEALTH7 min readBlogEGFR-Mutated Lung Cancer: The Latest U.S. Therapies and How to Access U.S. Top Specialists Second Opinion (2026)
Medebound HEALTH7 min readNew Targeted Therapy for EGFR Exon 20 Lung Cancer Patients and How a U.S. Second Opinion Can Help International Patient Get There Too
Medebound HEALTH7 min readA New Oral Drug for HER2-Mutated Lung Cancer Achieves 76% Response Rate — What a U.S. Remote Second Opinion Can Reveal
Medebound HEALTH7 min readBlogU.S. Second Opinion for ALK-Positive Lung Cancer: 5-Year Survival Now Reaches 76% With Next-Generation Therapy (2026)
Medebound HEALTH8 min readBlogCan a Pill Replace Chemo for MET Exon 14 Lung Cancer? U.S. Targeted Therapy Explained for International Patients Seeking a Remote Second Opinion in U.S. (2026)
Medebound HEALTH8 min readBlogKRAS Lung Cancer Treatment in 2026: The First Targeted Drugs Explained and How to Get a U.S. Remote Consultation
Medebound HEALTH7 min readBlogBRCA-Mutated Prostate Cancer: PARP Combinations That Double Progression-Free Survival in the U.S. (2026)
Medebound HEALTH7 min readBlogPluvicto Before Chemotherapy: How Metastatic Prostate Cancer Patients Access U.S. Remote Consultation for Radioligand Therapy (2026)
Medebound HEALTH11 min readCasesFrom Riyadh to United States: How a 17-Year-Old's Family Refused to Accept One Treatment Plan for Metastatic Osteosarcoma
Medebound HEALTH8 min readCasesHow a 60-Year-Old Prostate Cancer Patient in India Used a U.S. Second Opinion to Strengthen His Treatment Plan
Medebound HEALTH8 min readCasesHow a 48-Year-Old Woman in South Asia Used a U.S. Second Opinion to Rethink a Rare Sarcoma Diagnosis
Medebound HEALTH13 min readCasesA 65-Year-Old Canadian Patient with Metastatic Triple-Negative Breast Cancer Sought a US Second Opinion — and Found a Treatment Path Her Team Had Not Yet Considered
Medebound HEALTH12 min readCasesHow a 55-Year-Old Indian Patient with Metastatic Breast Cancer Used a US Second Opinion to Navigate a Confusing Receptor Switch
Medebound HEALTH13 min readCasesAfter a Third Cancer Recurrence, a Hong Kong Patient Asked a US Colorectal Specialist One Question — and the Answer Changed Her Treatment Plan
Medebound HEALTH10 min readCasesHow a 64-Year-Old Patient from Malaysia Accessed a Leading US Oncologist for a Stage IV Colon Cancer Remote Second Opinion
Medebound HEALTH12 min readCasesHow a UK Patient Got a US Remote Second Opinion on Her Adenoid Cystic Carcinoma — Without Travelling
Medebound HEALTH13 min readCasesFrom Uncertainty to Clarity: How a Hodgkin Lymphoma Patient in Middle East Found a Path Forward with a US Second Opinion
Medebound HEALTH9 min readCasesRemote Second Opinion with an MD Anderson-Affiliated Expert for Recurrent Hepatocellular Carcinoma
Medebound HEALTH9 min readCasesAutoimmune Encephalitis Second Opinion with a Johns Hopkins-Affiliated Expert for a Relapsing Case: A Seronegative Encephalopathy Case
